老年脓毒症患者急性肾损伤的临床特征与预后
该研究回顾性分析2016年4月1日至2018年12月31日天津市第一中心医院ICU收治的490例65岁以上脓毒症患者,比较急性肾损伤(AKI)组与非AKI组的临床特征及预后。AKI发生率为50.8%(249/490),AKI组ICU死亡率和28天死亡率均显著高于非AKI组。按KDIGO分期,分期越高肾脏替代治疗(RRT)比例越高、无机械通气天数越短、肾脏恢复率越低、ICU及28天死亡率越高。RRT组较非RRT组机械通气比例降低,但28天死亡率升高。多因素Cox回归显示SOFA评分、KDIGO分期、使用血管活性药物及机械通气是28天死亡的独立危险因素。
要点
- 老年脓毒症患者AKI发生率为50.8%(249/490),AKI组28天死亡率36.1%(90/249)显著高于非AKI组24.5%(59/241)。
- KDIGO分期越高预后越差:1期、2期、3期的28天死亡率分别为26.9%(25/93)、35.7%(25/70)、46.5%(40/86)。
- KDIGO 3期RRT比例为88.4%(76/86),肾脏恢复率仅37.2%(32/86),低于1期的71.0%(66/93)和2期的51.4%(36/70)。
- RRT组28天死亡率50.0%(55/110)高于非RRT组25.2%(35/139),但ICU死亡率两组无显著差异(27.3% vs. 19.4%,P>0.05)。
- SOFA评分(RR=1.214)、KDIGO分期(RR=4.077)、使用血管活性药物(RR=2.896)和机械通气(RR=5.787)是28天死亡的独立危险因素。
适用人群与场景
- 年龄超过65岁的脓毒症患者,收治于ICU。
- 研究纳入2016年4月1日至2018年12月31日天津市第一中心医院ICU的490例患者。
诊断标准与关键阈值
- 急性肾损伤诊断及分期采用KDIGO标准,分为1期、2期、3期。
研究设计与关键结果
- 回顾性分析490例65岁以上脓毒症患者,其中AKI组249例,非AKI组241例。
- AKI组较非AKI组年龄更大(72.0±7.2岁 vs. 68.8±5.1岁),APACHE II评分(23.1±6.1 vs. 22.0±3.7)和SOFA评分(9.4±3.8 vs. 6.1±3.5)更高,机械通气时间、ICU住院时间和总住院时间更长,ICU死亡率(22.9% vs. 14.1%)和28天死亡率(36.1% vs. 24.5%)更高,均P<0.05。
- KDIGO 1期93例、2期70例、3期86例;随分期升高,RRT比例增高(14.0%、30.0%、88.4%),28天内无机械通气天数缩短(20.0、8.0、8.0天),肾脏恢复率降低(71.0%、51.4%、37.2%),ICU死亡率(12.9%、38.6%、20.9%)和28天死亡率(26.9%、35.7%、46.5%)升高,均P<0.05。
- RRT组110例与非RRT组139例比较:RRT组机械通气比例降低(46.4% vs. 68.3%),28天内无机械通气天数延长(18.0天 vs. 10.0天),ICU住院时间(13.0天 vs. 10.0天)和总住院时间(22.5天 vs. 16.0天)延长,28天死亡率升高(50.0% vs. 25.2%),均P<0.01;ICU死亡率两组无显著差异(27.3% vs. 19.4%,P>0.05)。
- 多因素Cox回归显示SOFA评分(RR=1.214,95%CI 1.117-1.319)、KDIGO分期(RR=4.077,95%CI 1.850-8.982)、使用血管活性药物(RR=2.896,95%CI 1.502-5.584)和机械通气(RR=5.787,95%CI 1.512-22.156)是28天死亡的独立危险因素(均P<0.05)。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,老年脓毒症合并AKI患者KDIGO分期越高死亡率越高,应重视分期评估。
- 作者认为,RRT可降低机械通气比例,但可能不改善老年脓毒症合并AKI患者的预后。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To analyze the incidence of acute kidney injury (AKI) in elderly patients with sepsis, compare the clinical characteristics and prognosis between AKI and non-AKI elderly patients with sepsis, and to investigate the impact of classification of AKI and renal replacement therapy (RRT) on the outcome of elderly patients with sepsis.
METHODS: The clinical data of 490 septic patients over 65 years old, admitted to intensive care unit (ICU) of Tianjin First Center Hospital from April 1st, 2016 to December 31st, 2018 were retrospectively analyzed. The patients were divided into two groups according to those with or without AKI. The clinical characteristics of patients were compared, and subgroup analysis of elderly septic patients with AKI was performed according to Kidney Disease: Improving Global Outcomes (KDIGO) staging criteria and whether RRT was performed, to observe the effects of AKI staging and RRT on the prognosis of elderly septic patients with AKI. Multivariate Cox regression analysis was used to screen the risk factors of death in elderly patients with sepsis associated AKI.
RESULTS: (1) A total of 490 septic elderly patients were enrolled, including 249 patients with AKI and 241 patients without AKI, with the AKI incidence of 50.8%. Compared with non-AKI group, the patients in AKI group were older (years old: 72.0±7.2 vs. 68.8±5.1), acute physiology and chronic health evaluation II (APACHE II) score and sequential organ failure assessment (SOFA) score were evidently higher (23.1±6.1 vs. 22.0±3.7, 9.4±3.8 vs. 6.1±3.5); the duration of mechanical ventilation [days: 7.0 (5.0, 10.0) vs. 6.0 (3.0, 9.0)], length of ICU stay [days: 12.0 (7.0, 15.0) vs. 7.0 (4.0, 13.0)] and total length of hospital stay [days: 15.0 (10.0, 21.5) vs. 12.0 (7.0, 15.0)] were longer, and ICU mortality and 28-day mortality were evidently higher [22.9% (57/249) vs. 14.1% (34/241), 36.1% (90/249) vs. 24.5% (59/241), all P < 0.05]. (2) According to KDIGO staging, 93 patients were in stage 1, 70 in stage 2 and 86 in stage 3 of AKI. The rate of RRT was increased with increase in KDIGO staging [14.0% (13/93), 30.0% (21/70), 88.4% (76/86)], the duration without mechanical ventilation within 28 days was shortened [days: 20.0 (0, 23.0), 8.0 (0, 20.5), 8.0 (0, 13.0)], the rate of kidney recovery was decreased [71.0% (66/93), 51.4% (36/70), 37.2% (32/86)], meanwhile, the ICU and 28-day mortality was increased [12.9% (12/93), 38.6% (27/70), 20.9% (18/86), and 26.9% (25/93), 35.7% (25/70), 46.5% (40/86), all P < 0.05]. (3) 110 elderly septic patients with AKI were treated with RRT, and 139 without RRT. Compared with non-RRT group, the ratio of mechanical ventilation in RRT group was lowered [46.4% (51/110) vs. 68.3% (95/139)], the duration without mechanical ventilation within 28 days [days: 18.0 (0, 23.0) vs. 10.0 (0, 13.0)], the length of ICU stay [days: 13.0 (12.0, 17.9) vs. 10.0 (6.0, 14.0)] and the total length of hospital stay [days: 22.5 (15.0, 46.0) vs. 16.0 (12.0, 23.0)] were prolonged, and the 28-day mortality was evidently increased [50.0% (55/110) vs. 25.2% (35/139), all P < 0.01], however, no significant difference in ICU mortality was found [27.3% (30/110) vs. 19.4% (27/139), P > 0.05]. (4) Cox regression analysis showed that SOFA score [relative risk (RR) = 1.214, 95% confidence interval (95%CI) = 1.117-1.319], KDIGO stage (RR = 4.077, 95%CI = 1.850-8.982), vasoactive substance usage (RR = 2.896, 95%CI = 1.502-5.584), and mechanical ventilation (RR = 5.787, 95%CI = 1.512-22.156) were the risk factors of 28-day mortality in elderly septic patients with AKI (all P < 0.05).
CONCLUSIONS: The incidence of AKI for elderly septic patients with AKI was about 50%, who had a worse prognosis as compared with non-septic AKI patients. The higher the stage of KDIGO, the higher the mortality in elderly septic patients with AKI was. RRT can decrease the rate of mechanical ventilation, whereas, it may not improve the prognosis of elderly septic patients with AKI.
参考来源
- Wang J, Li J, Wang Y, et al. [Clinical characteristics and prognosis of acute kidney injury in elderly patients with sepsis]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019. PMID: 31441406. doi:10.3760/cma.j.issn.2095-4352.2019.07.008
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。